nodes	percent_of_prediction	percent_of_DWPC	metapath
Leucovorin—ABCC3—Vincristine—peripheral nervous system neoplasm	0.149	0.198	CbGbCtD
Leucovorin—ABCC3—Cisplatin—peripheral nervous system neoplasm	0.139	0.185	CbGbCtD
Leucovorin—ABCC3—Etoposide—peripheral nervous system neoplasm	0.136	0.181	CbGbCtD
Leucovorin—ABCC3—Doxorubicin—peripheral nervous system neoplasm	0.093	0.124	CbGbCtD
Leucovorin—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0677	0.09	CbGbCtD
Leucovorin—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0631	0.0839	CbGbCtD
Leucovorin—ABCC2—Etoposide—peripheral nervous system neoplasm	0.062	0.0824	CbGbCtD
Leucovorin—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0423	0.0562	CbGbCtD
Leucovorin—ABCC3—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00184	0.0793	CbGpPWpGaD
Leucovorin—ABCC2—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00146	0.0628	CbGpPWpGaD
Leucovorin—ABCC2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00124	0.0533	CbGpPWpGaD
Leucovorin—TYMS—Vitamin A—Tretinoin—peripheral nervous system neoplasm	0.00108	0.134	CbGdCrCtD
Leucovorin—TYMS—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.134	CbGdCrCtD
Leucovorin—ABCC3—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.00101	0.0434	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.001	0.0433	CbGpPWpGaD
Leucovorin—ABCC4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000946	0.0408	CbGpPWpGaD
Leucovorin—TYMS—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.000893	0.0385	CbGpPWpGaD
Leucovorin—TYMS—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.000818	0.102	CbGdCrCtD
Leucovorin—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000798	0.0344	CbGpPWpGaD
Leucovorin—TYMS—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000754	0.0937	CbGdCrCtD
Leucovorin—TYMS—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.000754	0.0937	CbGdCrCtD
Leucovorin—TYMS—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000754	0.0937	CbGdCrCtD
Leucovorin—TYMS—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.000754	0.0937	CbGdCrCtD
Leucovorin—ABCC3—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000607	0.0261	CbGpPWpGaD
Leucovorin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000578	0.0249	CbGpPWpGaD
Leucovorin—TYMS—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000572	0.071	CbGdCrCtD
Leucovorin—TYMS—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000572	0.071	CbGdCrCtD
Leucovorin—ABCC3—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000552	0.0238	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—NF2—peripheral nervous system neoplasm	0.00054	0.0233	CbGpPWpGaD
Leucovorin—ABCC4—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000519	0.0224	CbGpPWpGaD
Leucovorin—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000481	0.0207	CbGpPWpGaD
Leucovorin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000458	0.0197	CbGpPWpGaD
Leucovorin—ABCC2—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000438	0.0189	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000436	0.0188	CbGpPWpGaD
Leucovorin—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000395	0.00182	CcSEcCtD
Leucovorin—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000394	0.00182	CcSEcCtD
Leucovorin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000394	0.00182	CcSEcCtD
Leucovorin—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000394	0.00182	CcSEcCtD
Leucovorin—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000394	0.00182	CcSEcCtD
Leucovorin—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000391	0.0018	CcSEcCtD
Leucovorin—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00039	0.0018	CcSEcCtD
Leucovorin—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000389	0.00179	CcSEcCtD
Leucovorin—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000387	0.00178	CcSEcCtD
Leucovorin—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000381	0.00176	CcSEcCtD
Leucovorin—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000378	0.00174	CcSEcCtD
Leucovorin—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000376	0.00173	CcSEcCtD
Leucovorin—Chills—Etoposide—peripheral nervous system neoplasm	0.000373	0.00172	CcSEcCtD
Leucovorin—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000372	0.00172	CcSEcCtD
Leucovorin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000371	0.00171	CcSEcCtD
Leucovorin—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00037	0.00171	CcSEcCtD
Leucovorin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000368	0.0017	CcSEcCtD
Leucovorin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000368	0.0017	CcSEcCtD
Leucovorin—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000367	0.00169	CcSEcCtD
Leucovorin—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000367	0.00169	CcSEcCtD
Leucovorin—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000366	0.00169	CcSEcCtD
Leucovorin—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.000365	0.00168	CcSEcCtD
Leucovorin—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000364	0.00168	CcSEcCtD
Leucovorin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000363	0.00167	CcSEcCtD
Leucovorin—Infection—Vincristine—peripheral nervous system neoplasm	0.000362	0.00167	CcSEcCtD
Leucovorin—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000361	0.00166	CcSEcCtD
Leucovorin—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00036	0.00166	CcSEcCtD
Leucovorin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000358	0.00165	CcSEcCtD
Leucovorin—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000358	0.00165	CcSEcCtD
Leucovorin—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000357	0.00165	CcSEcCtD
Leucovorin—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000356	0.00164	CcSEcCtD
Leucovorin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000356	0.00164	CcSEcCtD
Leucovorin—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000355	0.00164	CcSEcCtD
Leucovorin—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000354	0.00163	CcSEcCtD
Leucovorin—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.000354	0.00163	CcSEcCtD
Leucovorin—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000353	0.00163	CcSEcCtD
Leucovorin—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000353	0.00163	CcSEcCtD
Leucovorin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000353	0.00163	CcSEcCtD
Leucovorin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000353	0.00163	CcSEcCtD
Leucovorin—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000352	0.00162	CcSEcCtD
Leucovorin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000348	0.00161	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000348	0.0016	CcSEcCtD
Leucovorin—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000347	0.0016	CcSEcCtD
Leucovorin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000344	0.00159	CcSEcCtD
Leucovorin—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000344	0.00158	CcSEcCtD
Leucovorin—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000342	0.00158	CcSEcCtD
Leucovorin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000341	0.00157	CcSEcCtD
Leucovorin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000341	0.00157	CcSEcCtD
Leucovorin—TYMS—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.000339	0.0421	CbGdCrCtD
Leucovorin—TYMS—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000339	0.0421	CbGdCrCtD
Leucovorin—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.000337	0.00156	CcSEcCtD
Leucovorin—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000337	0.00156	CcSEcCtD
Leucovorin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000337	0.00155	CcSEcCtD
Leucovorin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000336	0.00155	CcSEcCtD
Leucovorin—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000336	0.00155	CcSEcCtD
Leucovorin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000334	0.00154	CcSEcCtD
Leucovorin—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000333	0.00154	CcSEcCtD
Leucovorin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000333	0.00153	CcSEcCtD
Leucovorin—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000332	0.00153	CcSEcCtD
Leucovorin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00033	0.00152	CcSEcCtD
Leucovorin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00033	0.00152	CcSEcCtD
Leucovorin—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000329	0.00152	CcSEcCtD
Leucovorin—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000327	0.00151	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000326	0.00151	CcSEcCtD
Leucovorin—Malaise—Etoposide—peripheral nervous system neoplasm	0.000326	0.0015	CcSEcCtD
Leucovorin—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000326	0.0015	CcSEcCtD
Leucovorin—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000324	0.00149	CcSEcCtD
Leucovorin—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000323	0.00149	CcSEcCtD
Leucovorin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000322	0.00149	CcSEcCtD
Leucovorin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000322	0.00149	CcSEcCtD
Leucovorin—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000322	0.00149	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.00148	CcSEcCtD
Leucovorin—Infection—Cisplatin—peripheral nervous system neoplasm	0.00032	0.00148	CcSEcCtD
Leucovorin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00032	0.00148	CcSEcCtD
Leucovorin—ABCC4—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.000319	0.0138	CbGpPWpGaD
Leucovorin—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000318	0.00147	CcSEcCtD
Leucovorin—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.00147	CcSEcCtD
Leucovorin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000317	0.00146	CcSEcCtD
Leucovorin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000317	0.00146	CcSEcCtD
Leucovorin—Rash—Topotecan—peripheral nervous system neoplasm	0.000317	0.00146	CcSEcCtD
Leucovorin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000317	0.00146	CcSEcCtD
Leucovorin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000317	0.00146	CcSEcCtD
Leucovorin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000315	0.00146	CcSEcCtD
Leucovorin—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000315	0.00145	CcSEcCtD
Leucovorin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000315	0.00145	CcSEcCtD
Leucovorin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000315	0.00145	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000315	0.00145	CcSEcCtD
Leucovorin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000314	0.00145	CcSEcCtD
Leucovorin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000314	0.00145	CcSEcCtD
Leucovorin—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000314	0.00145	CcSEcCtD
Leucovorin—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000313	0.00145	CcSEcCtD
Leucovorin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000313	0.00144	CcSEcCtD
Leucovorin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000313	0.00144	CcSEcCtD
Leucovorin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000312	0.00144	CcSEcCtD
Leucovorin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000312	0.00144	CcSEcCtD
Leucovorin—Rash—Melphalan—peripheral nervous system neoplasm	0.000311	0.00143	CcSEcCtD
Leucovorin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00031	0.00143	CcSEcCtD
Leucovorin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000309	0.00143	CcSEcCtD
Leucovorin—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000307	0.00142	CcSEcCtD
Leucovorin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000307	0.00142	CcSEcCtD
Leucovorin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000304	0.0014	CcSEcCtD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.000304	0.0131	CbGpPWpGaD
Leucovorin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.0003	0.00139	CcSEcCtD
Leucovorin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.0003	0.00139	CcSEcCtD
Leucovorin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000299	0.00138	CcSEcCtD
Leucovorin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000299	0.00138	CcSEcCtD
Leucovorin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000299	0.00138	CcSEcCtD
Leucovorin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000298	0.00137	CcSEcCtD
Leucovorin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000298	0.00137	CcSEcCtD
Leucovorin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000296	0.00137	CcSEcCtD
Leucovorin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000296	0.00137	CcSEcCtD
Leucovorin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000295	0.00136	CcSEcCtD
Leucovorin—Infection—Etoposide—peripheral nervous system neoplasm	0.000293	0.00135	CcSEcCtD
Leucovorin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000293	0.00135	CcSEcCtD
Leucovorin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000293	0.00135	CcSEcCtD
Leucovorin—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.00135	CcSEcCtD
Leucovorin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000289	0.00133	CcSEcCtD
Leucovorin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000288	0.00133	CcSEcCtD
Leucovorin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000288	0.00133	CcSEcCtD
Leucovorin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000287	0.00132	CcSEcCtD
Leucovorin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000287	0.00132	CcSEcCtD
Leucovorin—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.00131	CcSEcCtD
Leucovorin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000281	0.0013	CcSEcCtD
Leucovorin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00028	0.00129	CcSEcCtD
Leucovorin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000279	0.00129	CcSEcCtD
Leucovorin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000279	0.00129	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000278	0.00128	CcSEcCtD
Leucovorin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000271	0.00125	CcSEcCtD
Leucovorin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000268	0.00124	CcSEcCtD
Leucovorin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000268	0.00123	CcSEcCtD
Leucovorin—ABCC4—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.000266	0.0115	CbGpPWpGaD
Leucovorin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000266	0.00122	CcSEcCtD
Leucovorin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000263	0.00121	CcSEcCtD
Leucovorin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000261	0.00121	CcSEcCtD
Leucovorin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000259	0.0012	CcSEcCtD
Leucovorin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000259	0.00119	CcSEcCtD
Leucovorin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000257	0.00119	CcSEcCtD
Leucovorin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000257	0.00118	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000255	0.00118	CcSEcCtD
Leucovorin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000255	0.00117	CcSEcCtD
Leucovorin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000254	0.00117	CcSEcCtD
Leucovorin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000254	0.00117	CcSEcCtD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.000253	0.0109	CbGpPWpGaD
Leucovorin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000253	0.00117	CcSEcCtD
Leucovorin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000252	0.00116	CcSEcCtD
Leucovorin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00025	0.00115	CcSEcCtD
Leucovorin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000249	0.00115	CcSEcCtD
Leucovorin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000243	0.00112	CcSEcCtD
Leucovorin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000242	0.00112	CcSEcCtD
Leucovorin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000241	0.00111	CcSEcCtD
Leucovorin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000241	0.00111	CcSEcCtD
Leucovorin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00024	0.00111	CcSEcCtD
Leucovorin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000238	0.0011	CcSEcCtD
Leucovorin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000238	0.0011	CcSEcCtD
Leucovorin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000237	0.00109	CcSEcCtD
Leucovorin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.00109	CcSEcCtD
Leucovorin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000235	0.00108	CcSEcCtD
Leucovorin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.00108	CcSEcCtD
Leucovorin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000233	0.00108	CcSEcCtD
Leucovorin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000233	0.00108	CcSEcCtD
Leucovorin—TYMS—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.000233	0.029	CbGdCrCtD
Leucovorin—TYMS—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000233	0.01	CbGpPWpGaD
Leucovorin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000232	0.00107	CcSEcCtD
Leucovorin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000231	0.00107	CcSEcCtD
Leucovorin—Rash—Vincristine—peripheral nervous system neoplasm	0.00023	0.00106	CcSEcCtD
Leucovorin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00023	0.00106	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000228	0.00983	CbGpPWpGaD
Leucovorin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000225	0.00104	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000222	0.00956	CbGpPWpGaD
Leucovorin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00022	0.00102	CcSEcCtD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000218	0.00938	CbGpPWpGaD
Leucovorin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000217	0.001	CcSEcCtD
Leucovorin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000216	0.000998	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000214	0.00924	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000214	0.00922	CbGpPWpGaD
Leucovorin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000212	0.000977	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.00021	0.00907	CbGpPWpGaD
Leucovorin—Chills—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000964	CcSEcCtD
Leucovorin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000209	0.000963	CcSEcCtD
Leucovorin—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000949	CcSEcCtD
Leucovorin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000205	0.000945	CcSEcCtD
Leucovorin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000203	0.000937	CcSEcCtD
Leucovorin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000203	0.000936	CcSEcCtD
Leucovorin—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000935	CcSEcCtD
Leucovorin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000202	0.000932	CcSEcCtD
Leucovorin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000916	CcSEcCtD
Leucovorin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000195	0.0009	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000195	0.0084	CbGpPWpGaD
Leucovorin—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000892	CcSEcCtD
Leucovorin—ABCC3—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000193	0.00831	CbGpPWpGaD
Leucovorin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000191	0.000883	CcSEcCtD
Leucovorin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000878	CcSEcCtD
Leucovorin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000868	CcSEcCtD
Leucovorin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000188	0.000866	CcSEcCtD
Leucovorin—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000865	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000187	0.00807	CbGpPWpGaD
Leucovorin—Rash—Etoposide—peripheral nervous system neoplasm	0.000186	0.000858	CcSEcCtD
Leucovorin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000186	0.000858	CcSEcCtD
Leucovorin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000847	CcSEcCtD
Leucovorin—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000843	CcSEcCtD
Leucovorin—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000839	CcSEcCtD
Leucovorin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000837	CcSEcCtD
Leucovorin—ABCC4—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000181	0.00781	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000181	0.0078	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000178	0.00769	CbGpPWpGaD
Leucovorin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000822	CcSEcCtD
Leucovorin—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000176	0.00081	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000176	0.00756	CbGpPWpGaD
Leucovorin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000175	0.000809	CcSEcCtD
Leucovorin—ABCC3—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000175	0.00754	CbGpPWpGaD
Leucovorin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000803	CcSEcCtD
Leucovorin—TYMS—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000173	0.00747	CbGpPWpGaD
Leucovorin—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000787	CcSEcCtD
Leucovorin—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.00078	CcSEcCtD
Leucovorin—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000776	CcSEcCtD
Leucovorin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000774	CcSEcCtD
Leucovorin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00077	CcSEcCtD
Leucovorin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000763	CcSEcCtD
Leucovorin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.00076	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000164	0.00709	CbGpPWpGaD
Leucovorin—Infection—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000758	CcSEcCtD
Leucovorin—Shock—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000751	CcSEcCtD
Leucovorin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.00075	CcSEcCtD
Leucovorin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000747	CcSEcCtD
Leucovorin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000741	CcSEcCtD
Leucovorin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000728	CcSEcCtD
Leucovorin—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000727	CcSEcCtD
Leucovorin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000712	CcSEcCtD
Leucovorin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000706	CcSEcCtD
Leucovorin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000702	CcSEcCtD
Leucovorin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000695	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.00015	0.00648	CbGpPWpGaD
Leucovorin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000691	CcSEcCtD
Leucovorin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000686	CcSEcCtD
Leucovorin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000148	0.00068	CcSEcCtD
Leucovorin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000673	CcSEcCtD
Leucovorin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000672	CcSEcCtD
Leucovorin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000663	CcSEcCtD
Leucovorin—ABCC3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000143	0.00618	CbGpPWpGaD
Leucovorin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000659	CcSEcCtD
Leucovorin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000658	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	0.000142	0.00611	CbGpPWpGaD
Leucovorin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000653	CcSEcCtD
Leucovorin—ABCC2—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000139	0.00598	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000138	0.00595	CbGpPWpGaD
Leucovorin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.00063	CcSEcCtD
Leucovorin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000629	CcSEcCtD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	0.000136	0.00584	CbGpPWpGaD
Leucovorin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000624	CcSEcCtD
Leucovorin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000622	CcSEcCtD
Leucovorin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000614	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.00061	CcSEcCtD
Leucovorin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000609	CcSEcCtD
Leucovorin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000606	CcSEcCtD
Leucovorin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000604	CcSEcCtD
Leucovorin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000603	CcSEcCtD
Leucovorin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000603	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000131	0.00563	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00013	0.0056	CbGpPWpGaD
Leucovorin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000582	CcSEcCtD
Leucovorin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000577	CcSEcCtD
Leucovorin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000562	CcSEcCtD
Leucovorin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000561	CcSEcCtD
Leucovorin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000558	CcSEcCtD
Leucovorin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000558	CcSEcCtD
Leucovorin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000548	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.000118	0.00509	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000117	0.00505	CbGpPWpGaD
Leucovorin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000117	0.00054	CcSEcCtD
Leucovorin—TYMS—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	0.000116	0.00499	CbGpPWpGaD
Leucovorin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000522	CcSEcCtD
Leucovorin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.00052	CcSEcCtD
Leucovorin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000507	CcSEcCtD
Leucovorin—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000109	0.00472	CbGpPWpGaD
Leucovorin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000505	CcSEcCtD
Leucovorin—TYMS—G1/S Transition—MYC—peripheral nervous system neoplasm	0.000109	0.0047	CbGpPWpGaD
Leucovorin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.0005	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.000107	0.00462	CbGpPWpGaD
Leucovorin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000485	CcSEcCtD
Leucovorin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000483	CcSEcCtD
Leucovorin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000481	CcSEcCtD
Leucovorin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000481	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—AURKA—peripheral nervous system neoplasm	0.000104	0.00446	CbGpPWpGaD
Leucovorin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000467	CcSEcCtD
Leucovorin—Nausea—Epirubicin—peripheral nervous system neoplasm	9.83e-05	0.000453	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	9.82e-05	0.00423	CbGpPWpGaD
Leucovorin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	9.73e-05	0.000449	CcSEcCtD
Leucovorin—ABCC3—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.69e-05	0.00418	CbGpPWpGaD
Leucovorin—Rash—Doxorubicin—peripheral nervous system neoplasm	9.65e-05	0.000445	CcSEcCtD
Leucovorin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	9.64e-05	0.000445	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—CHEK2—peripheral nervous system neoplasm	9.26e-05	0.00399	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	9.19e-05	0.00396	CbGpPWpGaD
Leucovorin—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.09e-05	0.000419	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	8.92e-05	0.00384	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GNS—peripheral nervous system neoplasm	8.47e-05	0.00365	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—NME1—peripheral nervous system neoplasm	8.12e-05	0.0035	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	8.05e-05	0.00347	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IFNB1—peripheral nervous system neoplasm	7.88e-05	0.0034	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—COX2—peripheral nervous system neoplasm	7.81e-05	0.00337	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	7.5e-05	0.00323	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	7.31e-05	0.00315	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—KNG1—peripheral nervous system neoplasm	7.3e-05	0.00315	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	7.03e-05	0.00303	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GNS—peripheral nervous system neoplasm	7.01e-05	0.00302	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	6.96e-05	0.003	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.87e-05	0.00296	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—NME1—peripheral nervous system neoplasm	6.72e-05	0.0029	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—BIRC5—peripheral nervous system neoplasm	6.71e-05	0.00289	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—COX2—peripheral nervous system neoplasm	6.47e-05	0.00279	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—GNAS—peripheral nervous system neoplasm	6.38e-05	0.00275	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—HGF—peripheral nervous system neoplasm	6.08e-05	0.00262	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.88e-05	0.00253	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.79e-05	0.0025	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.77e-05	0.00249	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	5.72e-05	0.00246	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.53e-05	0.00238	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	5.49e-05	0.00237	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.42e-05	0.00234	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ENO2—peripheral nervous system neoplasm	5.13e-05	0.00221	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	4.97e-05	0.00214	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.83e-05	0.00208	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.66e-05	0.00201	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.57e-05	0.00197	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	4.45e-05	0.00192	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PTPN11—peripheral nervous system neoplasm	4.44e-05	0.00191	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—BCHE—peripheral nervous system neoplasm	4.33e-05	0.00187	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ENO2—peripheral nervous system neoplasm	4.25e-05	0.00183	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.13e-05	0.00178	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—TH—peripheral nervous system neoplasm	4.07e-05	0.00176	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—BCHE—peripheral nervous system neoplasm	3.59e-05	0.00155	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.42e-05	0.00147	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—TH—peripheral nervous system neoplasm	3.37e-05	0.00145	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	3.37e-05	0.00145	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	3.34e-05	0.00144	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GNAS—peripheral nervous system neoplasm	3.33e-05	0.00143	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ABCB1—peripheral nervous system neoplasm	3.26e-05	0.00141	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MYC—peripheral nervous system neoplasm	3.01e-05	0.0013	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GNAS—peripheral nervous system neoplasm	2.75e-05	0.00119	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ABCB1—peripheral nervous system neoplasm	2.7e-05	0.00116	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	2.67e-05	0.00115	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TP53—peripheral nervous system neoplasm	2.47e-05	0.00107	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	2.04e-05	0.00088	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	1.95e-05	0.000841	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	1.72e-05	0.000743	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—AKT1—peripheral nervous system neoplasm	8.98e-06	0.000387	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—AKT1—peripheral nervous system neoplasm	7.43e-06	0.00032	CbGpPWpGaD
